Course Summary
Contact Hours:
2.5 Contact Hours, including 2.5 Advanced Pharmacology Hours
Author:
Heather Rhodes (APRN-BC)
This peer-reviewed course is applicable for the following professions:
Advanced Practice Registered Nurse (APRN), Certified Nurse Midwife, Certified Nurse Practitioner, Certified Registered Nurse Anesthetist (CRNA), Certified Registered Nurse Practitioner, Clinical Nurse Specialist (CNS), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Midwife (MW), Nursing Student, Registered Nurse (RN), Registered Nurse Practitioner
Accreditations:
The American Nurses Credentialing Center (ANCC)
State Approvals:
Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353
Course Description:
This course discusses best practices for assessing, diagnosing, and treating this complex mental health condition. Upon completing this module, healthcare providers will be able to develop a differential diagnosis and a comprehensive treatment plan that includes both pharmacologic and non-pharmacologic interventions.
Outcomes:
≥ 92% of participants will know best practices for assessing, diagnosing, and treating borderline personality disorder.
Objectives:
After completing this continuing education course, the participant will be able to:
- Explain the prevalence and characteristics of borderline personality disorder (BPD).
- Summarize the pathogenesis of BPD.
- List two theories for the development of BPD.
- Identify risk factors and core diagnostic features for BPD.
- Describe available screening tools for the diagnosis of BPD.
- Compare symptoms of and differential diagnoses for BPD.
- Identify two treatment options for BPD.
- Describe challenges with pharmacological treatment modalities.
Disclosures:
CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
